Ming-Rong Zhang Selected Research

Drug Therapy (Chemotherapy)

8/2021	Quantitative Radionuclide Imaging Analysis of Enhanced Drug Delivery Induced by Photoimmunotherapy.
1/2021	Neuroprotective effects of minocycline and KML29, a potent inhibitor of monoacylglycerol lipase, in an experimental stroke model: a small-animal positron emission tomography study.
1/2015	PET imaging of apoptosis in tumor-bearing mice and rabbits after paclitaxel treatment with (18)F(-)Labeled recombinant human His10-annexin V.
4/2011	Evaluation of chemotherapy response in VX2 rabbit lung cancer with 18F-labeled C2A domain of synaptotagmin I.
6/2010	Synthesis and evaluation of [11C]XR9576 to assess the function of drug efflux transporters using PET.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ming-Rong Zhang Research Topics

Disease

61	Neoplasms (Cancer) 01/2024 - 10/2009
31	Alzheimer Disease (Alzheimer's Disease) 01/2024 - 04/2004
19	Neuroinflammatory Diseases 01/2024 - 11/2007
15	Breast Neoplasms (Breast Cancer) 10/2023 - 04/2009
12	Neurodegenerative Diseases (Neurodegenerative Disease) 02/2024 - 11/2007
10	Inflammation (Inflammations) 10/2023 - 07/2009
9	Tauopathies 01/2024 - 03/2011
9	Hypoxia (Hypoxemia) 12/2023 - 09/2015
8	Pancreatic Neoplasms (Pancreatic Cancer) 05/2022 - 01/2013
8	Central Nervous System Diseases (CNS Diseases) 01/2022 - 10/2012
6	Schizophrenia (Dementia Praecox) 01/2023 - 01/2017
6	Neoplasm Metastasis (Metastasis) 06/2022 - 10/2014
5	Brain Diseases (Brain Disorder) 01/2023 - 04/2004
5	Ischemia 01/2021 - 06/2010
5	Melanoma (Melanoma, Malignant) 01/2021 - 10/2014
5	Dementia (Dementias) 01/2019 - 04/2005
4	Parkinson Disease (Parkinson's Disease) 02/2024 - 01/2016
4	Mental Disorders (Mental Disorder) 01/2024 - 02/2009
4	Brain Neoplasms (Brain Tumor) 12/2023 - 01/2007
4	Nervous System Diseases (Neurological Disorders) 10/2022 - 01/2012
4	Cognitive Dysfunction 06/2018 - 01/2016
4	Human Influenza (Influenza) 01/2014 - 02/2008
3	Atrophy 12/2023 - 03/2011
3	Major Depressive Disorder (Major Depressive Disorders) 10/2021 - 04/2014
3	Carcinoma (Carcinomatosis) 08/2020 - 01/2015
3	Substance-Related Disorders (Drug Abuse) 01/2020 - 01/2018
3	Glioblastoma (Glioblastoma Multiforme) 09/2019 - 01/2016
3	Lung Neoplasms (Lung Cancer) 12/2018 - 04/2011
3	Pneumonia (Pneumonitis) 01/2016 - 09/2011
3	Amyloid Plaque 12/2015 - 09/2013
3	Brain Injuries (Brain Injury) 06/2014 - 11/2009
2	Stomach Neoplasms (Stomach Cancer) 07/2022 - 07/2020
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 07/2022 - 11/2015
2	Gastrointestinal Neoplasms (Gastrointestinal Cancer) 07/2022 - 06/2018
2	Atherosclerosis 10/2021 - 08/2018
2	Stroke (Strokes) 01/2021 - 06/2014

Drug/Important Bio-Agent (IBA)

45	Proteins (Proteins, Gene)FDA Link 01/2024 - 11/2007
27	LigandsIBA 05/2023 - 04/2004
19	Biomarkers (Surrogate Marker)IBA 12/2023 - 11/2008
13	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 10/2023 - 04/2009
13	Peptides (Polypeptides)IBA 01/2023 - 03/2011
12	Amyloid (Amyloid Fibrils)IBA 01/2024 - 03/2011
9	Glutamic Acid (Glutamate)FDA Link 01/2023 - 02/2009
8	metabotropic glutamate receptor type 1IBA 01/2023 - 10/2012
8	GABA-A Receptors (GABA(A) Receptor)IBA 01/2010 - 04/2004
7	AcidsIBA 12/2018 - 01/2011
6	IntegrinsIBA 12/2020 - 04/2014
5	acetamideIBA 01/2024 - 10/2009
5	copper (II) diacetyl- di(N(4)- methylthiosemicarbazone)IBA 12/2023 - 09/2014
5	Metabotropic Glutamate Receptors (Metabotropic Glutamate Receptor)IBA 01/2023 - 10/2012
5	RadiopharmaceuticalsIBA 01/2023 - 01/2018
5	ErbB Receptors (EGF Receptor)IBA 07/2022 - 09/2021
5	Norepinephrine Plasma Membrane Transport Proteins (Norepinephrine Transporter)IBA 11/2020 - 11/2013
4	Phosphotransferases (Kinase)IBA 02/2024 - 06/2012
4	N- benzyl- N- methyl- 2- (7,8- dihydro- 7- (2- fluoroethyl)- 8- oxo- 2- phenyl- 9H- purin- 9- yl)acetamideIBA 01/2024 - 01/2012
4	Red Fluorescent ProteinIBA 12/2022 - 04/2016
4	Cetuximab (Erbitux)FDA Link 07/2022 - 06/2018
4	AntibodiesIBA 05/2022 - 11/2012
4	pyridineIBA 07/2021 - 10/2014
4	cyclic arginine-glycine-aspartic acid peptideIBA 06/2018 - 04/2014
4	AcetylcholinesteraseIBA 01/2018 - 04/2005
4	Oseltamivir (Tamiflu)FDA Link 01/2014 - 02/2008
3	tau Proteins (tau Protein)IBA 01/2024 - 12/2022
3	Serotonin (5 Hydroxytryptamine)IBA 01/2024 - 10/2002
3	LipopolysaccharidesIBA 10/2023 - 09/2011
3	Oncogene Proteins (Oncogene Protein)IBA 01/2023 - 10/2014
3	Monoacylglycerol LipasesIBA 01/2022 - 10/2019
3	Radioisotopes (Radionuclides)IBA 01/2021 - 01/2016
3	Therapeutic UsesIBA 01/2021 - 04/2016
3	Neuroprotective AgentsIBA 01/2021 - 09/2013
3	N-methylbenzamideIBA 01/2020 - 09/2013
3	metabotropic glutamate receptor 2IBA 01/2020 - 01/2017
3	ElacridarIBA 02/2019 - 11/2010
3	isobutyric acidIBA 12/2018 - 10/2012
3	Amino Acid Transport Systems (Amino Acid Transporter)IBA 12/2018 - 05/2015
3	arginyl-glycyl-aspartic acidIBA 06/2018 - 01/2016
3	Glucose (Dextrose)FDA LinkGeneric 09/2017 - 10/2012
3	Monoclonal AntibodiesIBA 03/2015 - 01/2013
3	PropionatesIBA 03/2013 - 04/2005
3	Acetates (Acetic Acid Esters)FDA Link 03/2013 - 04/2005
3	Phosphates (Orthophosphate)IBA 05/2011 - 02/2008
3	Ro 64-0802IBA 05/2011 - 02/2008
2	Leucine (L-Leucine)FDA Link 02/2024 - 06/2020
2	Diacetyl (Biacetyl)IBA 12/2023 - 09/2015
2	Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA 10/2023 - 08/2014
2	benzothiazoleIBA 05/2023 - 01/2017
2	Phosphoric Diester Hydrolases (Phosphodiesterases)IBA 01/2023 - 01/2019
2	Immune Checkpoint InhibitorsIBA 01/2023 - 06/2022
2	CholesterolIBA 10/2022 - 10/2021
2	PolymersIBA 06/2022 - 01/2021
2	EndocannabinoidsIBA 01/2022 - 01/2018
2	64Cu- cyclam- RAFT- cyclo(arginyl- glycyl- aspartyl- phenylalanyl- lysyl)4IBA 12/2020 - 06/2018
2	Norepinephrine (Noradrenaline)FDA LinkGeneric 11/2020 - 01/2017
2	fluoroazomycin arabinosideIBA 08/2020 - 11/2015

Therapy/Procedure

23	Therapeutics 10/2023 - 04/2009
6	Precision Medicine 01/2021 - 01/2014
6	Radiotherapy 12/2020 - 04/2014
5	Drug Therapy (Chemotherapy) 08/2021 - 06/2010
4	Radioimmunotherapy 07/2022 - 06/2018
3	Intravenous Injections 11/2022 - 05/2011